Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with amnestic mild cognitive impairment (a type of memory problem that is more than normal ageing but not yet dementia)
- People who have a family member, friend, or carer who knows them well and can provide information about them to the study team
- People whose general health has been stable for around 3 months before the screening visit, as assessed by the study doctor
- People whose medications have been stable for around 4 weeks before the screening visit, as assessed by the study doctor
- People who are able to complete the initial assessments at the start of the trial
Who may not be able to join:
- People who have been diagnosed with a brain or nervous system disease other than mild cognitive impairment
- People who have had a significant stroke
- People who have, or have had in the past year, a focal brain lesion, a head injury involving loss of consciousness, or a major psychiatric condition such as psychosis, major depression, bipolar disorder, or alcohol or substance misuse
- People whose vision or hearing difficulties would prevent them from taking part in the study activities
- People who have diabetes and are currently taking medication to manage it
- People with significantly elevated liver enzyme levels (confirm with trial site)
- People with an active cancer diagnosis (stable prostate cancer and certain skin cancers may be acceptable — confirm with trial site)
- People who have had epilepsy or a seizure within the past year
- People who are unable to have an MRI scan, for example due to claustrophobia, metal implants in the head or face, or a pacemaker
- People with serious medical illness or organ problems, such as poorly controlled high blood pressure, heart disease, chronic lung disease, liver disease, or kidney disease
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Suzanne Craft, PhD, Wake Forest University Health Sciences
Phone: (336) 713-8010
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cerebrospinal Fluid (CSF) Abeta42
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.